{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:01:21Z","timestamp":1790704881658,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministry of Science","award":["AGL-2008-03710"],"award-info":[{"award-number":["AGL-2008-03710"]}]},{"name":"Spanish Ministry of Science","award":["AGL-2011-22485"],"award-info":[{"award-number":["AGL-2011-22485"]}]},{"name":"European Community\u2019s Seventh Framework Programme","award":["FP7-228394"],"award-info":[{"award-number":["FP7-228394"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.antiviral.2014.05.020","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T12:07:01Z","timestamp":1402920421000},"page":"165-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs"],"prefix":"10.1016","volume":"108","author":[{"given":"N\u00faria","family":"Busquets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"L\u00f3pez-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Solanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Galindo-Cardiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Xavier","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Bensaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Warimwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.05.020_b0005","doi-asserted-by":"crossref","first-page":"e36757","DOI":"10.1371\/journal.pone.0036757","article-title":"Culex pipiens, an experimental efficient vector of west Nile and Rift Valley fever viruses in the Maghreb region","volume":"7","author":"Amraoui","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.05.020_b0010","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1016\/j.vaccine.2007.04.002","article-title":"Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge","volume":"25","author":"Antonis","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.05.020_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-8579(02)00295-9","article-title":"Rift Valley fever: an uninvited zoonosis in the Arabian peninsula","volume":"21","author":"Balkhy","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2014.05.020_b0020","first-page":"45","article-title":"An inactivated rift valley fever vaccine","volume":"48","author":"Barnard","year":"1977","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"10.1016\/j.antiviral.2014.05.020_b0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.coviro.2012.02.017","article-title":"Breaking the chain: Rift Valley fever virus control via livestock vaccination","volume":"2","author":"Bird","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2014.05.020_b0030","first-page":"8","article-title":"Molecular biology of rift valley fever virus","volume":"4","author":"Bouloy","year":"2010","journal-title":"Open Virol. J."},{"key":"10.1016\/j.antiviral.2014.05.020_b0035","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.vaccine.2005.08.091","article-title":"Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge","volume":"24","author":"Breathnach","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.05.020_b0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/vbz.2009.0205","article-title":"Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates","volume":"10","author":"Busquets","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2014.05.020_b0045","doi-asserted-by":"crossref","first-page":"e5997","DOI":"10.1371\/journal.pone.0005997","article-title":"Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA)","volume":"4","author":"Chiam","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.05.020_b0050","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.05.020_b0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.20506\/rst.23.2.1500","article-title":"Rift Valley fever","volume":"23","author":"Gerdes","year":"2004","journal-title":"Rev. Sci. Technol."},{"key":"10.1016\/j.antiviral.2014.05.020_b0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virol.2006.08.002","article-title":"Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins","volume":"357","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.05.020_b0065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.virol.2007.04.014","article-title":"Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins","volume":"366","author":"Gorchakov","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.05.020_b0070","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2460\/ajvr.1980.41.10.1559","article-title":"Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep","volume":"41","author":"Harrington","year":"1980","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2014.05.020_b0075","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1017\/S0950268808001696","article-title":"An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus","volume":"137","author":"Heise","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.antiviral.2014.05.020_b0080","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/CVI.00182-09","article-title":"A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity","volume":"16","author":"Holman","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2014.05.020_b0085","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.vaccine.2010.01.001","article-title":"Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.05.020_b0090","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3201\/eid1709.110506","article-title":"Rift valley Fever vaccine development, progress and constraints","volume":"17","author":"Kortekaas","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.05.020_b0095","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1371\/journal.pntd.0002309","article-title":"A Single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a Lethal RVFV infection","volume":"7","author":"Lopez-Gil","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2014.05.020_b0100","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.vaccine.2012.10.118","article-title":"Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.05.020_b0105","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.vaccine.2013.08.003","article-title":"Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.05.020_b0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2014.05.020_b0115","doi-asserted-by":"crossref","first-page":"e77461","DOI":"10.1371\/journal.pone.0077461","article-title":"A single vaccination with an improved nonspreading rift valley fever virus vaccine provides sterile immunity in lambs","volume":"8","author":"Oreshkova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.05.020_b0120","doi-asserted-by":"crossref","first-page":"14926","DOI":"10.1073\/pnas.1112149108","article-title":"Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice","volume":"108","author":"Papin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.05.020_b0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet. Res."},{"key":"10.1016\/j.antiviral.2014.05.020_b0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating 50 percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2014.05.020_b0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3201\/eid1504.081045","article-title":"Rift Valley fever, Mayotte, 2007\u20132008","volume":"15","author":"Sissoko","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.05.020_b0140","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.antiviral.2014.05.020_b0145","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/CVI.00220-10","article-title":"Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine","volume":"17","author":"Soi","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2014.05.020_b0150","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.05.020_b0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1743-422X-10-349","article-title":"Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice","volume":"10","author":"Warimwe","year":"2013","journal-title":"Virol. J."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:25:20Z","timestamp":1746253520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214001648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":31,"alternative-id":["S0166354214001648"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.05.020","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}